{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:06:51Z","timestamp":1792426011635,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.12.059","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T10:21:09Z","timestamp":1451989269000},"page":"735-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs"],"prefix":"10.1016","volume":"34","author":[{"given":"Suba","family":"Sakthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Palaniyandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh D.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.12.059_bib0165","series-title":"WHO report 2014","article-title":"Global tuberculosis, report. Epidemiology, strategy, financing","author":"World Health Organisation","year":"2014"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0170","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG\u2014implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0175","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1099\/00221287-148-10-2967","article-title":"Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv","volume":"148","author":"Camus","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.femsre.2004.06.002","article-title":"Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components","volume":"28","author":"Sutcliffe","year":"2004","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0185","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1128\/IAI.69.8.4980-4987.2001","article-title":"Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst","volume":"69","author":"Piddington","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0190","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/sj.emboj.7601048","article-title":"LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis","volume":"25","author":"Sulzenbacher","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0195","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1016\/j.vaccine.2007.07.042","article-title":"A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties","volume":"25","author":"Henao-Tamayo","year":"2007","journal-title":"Vaccine"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2015.12.059_bib0200","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1099\/00221287-146-4-1011","article-title":"The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis","volume":"146","author":"Bigi","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/viru.2.3.15888","article-title":"Knockout mutation of p27\u2013p55 operon severely reduces replication of Mycobacterium bovis in a macrophagic cell line and survival in a mouse model of infection","volume":"2","author":"Bianco","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.micinf.2003.10.010","article-title":"The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis","volume":"6","author":"Bigi","year":"2004","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.micres.2013.02.007","article-title":"The lpqS knockout mutant of Mycobacterium tuberculosis is attenuated in macrophages","volume":"168","author":"Sakthi","year":"2013","journal-title":"Microbiol Res"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tube.2006.01.022","article-title":"The use of mutant mycobacteria as new vaccines to prevent tuberculosis","volume":"86","author":"Hernandez Pando","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0225","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1099\/jmm.0.46983-0","article-title":"Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant","volume":"56","author":"Senaratne","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0230","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0235","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0240","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.micinf.2005.04.001","article-title":"Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis","volume":"7","author":"Sambandamurthy","year":"2005","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chom.2008.01.002","article-title":"Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain","volume":"3","author":"Lee","year":"2008","journal-title":"Cell Host Microb"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0250","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1128\/JB.00038-13","article-title":"Polyphosphate deficiency in Mycobacterium tuberculosis is associated with enhanced drug susceptibility and impaired growth in guinea pigs","volume":"195","author":"Singh","year":"2013","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.qco.0000168380.08895.9a","article-title":"Recent developments in tuberculosis vaccines","volume":"18","author":"Haile","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0260","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tube.2003.12.006","article-title":"Gene expression profile of Mycobacterium tuberculosis in a non-replicating state","volume":"84","author":"Muttucumaru","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0270","doi-asserted-by":"crossref","first-page":"e3496","DOI":"10.1371\/journal.pone.0003496","article-title":"PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence","volume":"3","author":"Gonzalo-Asensio","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2958.2010.07431.x","article-title":"A novel copper-responsive regulon in Mycobacterium tuberculosis","volume":"79","author":"Festa","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M. tuberculosis infection","volume":"4","author":"Redford","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0285","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0290","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0295","series-title":"Tuberculosis","first-page":"135","article-title":"Guinea pig model of tuberculosis","author":"McMurray","year":"1994"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0300","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0305","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/02770906809100348","article-title":"Aerogenic BCG vaccination against tuberculosis in animal and human subjects","volume":"5","author":"Rosenthal","year":"1968","journal-title":"J Asthma"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0310","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/CVI.00700-13","article-title":"Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination","volume":"21","author":"Aguilo","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0315","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0962-8479(93)90067-8","article-title":"BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route","volume":"74","author":"Lagranderie","year":"1993","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.vaccine.2015.12.059_bib0320","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.vaccine.2005.03.001","article-title":"New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development","volume":"23","author":"Kamath","year":"2005","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T06:52:00Z","timestamp":1537080720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15018708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X15018708"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}